Michael S. Watson, MS, PhD, FACMG (Washington University) - "Genome Screening: Prenatal, Newborns, Adults"
2021 Advances in Precision Medicine Seminar Series
Dr. Watson is an Adjunct Professor of Pediatrics at Washington University School of Medicine and a former Executive Director of the American College of Medical Genetics and Genomics and the ACMG Foundation for Genetic and Genomic Medicine. He was also a co-P.I. for the ClinGen Resource Project, an NIH/NHGRI funded project to clinically annotate genome variation until January 2020 and remains on its Steering Committee. Prior to this, he was a project director of HRSA’s National Coordinating Center for Regional Genetics and Newborn Screening Collaboratives and for NIH/NICHD’s Newborn Screening Translational Research Network (NBSTRN) Coordinating Center (from 2007-2019). He also directed the HRSA funded project “Newborn Screening: Toward a Uniform Screening Panel and System”, was co-chair of the NIH/DOE Task Force on Genetic Testing from 1995 through 1997, served on the Board of Directors of the American College of Medical Genetics (1992-1998) and was a Vice President for Laboratory Affairs, and chaired numerous ACMG Committees. He was a director of Clinical and Molecular Cytogenetics at Washington University School of Medicine in St. Louis, Professor of Pediatrics and Genetics (1986–2001), Director of the Medical Genetics Training Program (1996-1999) and is certified by the American Board of Medical Genetics (ABMG) in Clinical Cytogenetics and Genomics and as a PhD Medical Geneticist. Dr. Watson received his MS in Medical Genetics and his PhD in Physiology & Biophysics from the University of Alabama at Birmingham while focusing on human medical genetics; his postdoctoral training was in the Medical Genetics Training Program at Yale University School of Medicine where he was the Associate Director of Clinical Cytogenetics.
Monthly seminar series hosted by the Precision Medicine Resource of the Irving Institute for Clinical and Translational Research and featuring leaders in the Precision Medicine field from across the nation.